Bicalutamide
Bicalutamide blocks androgen signalling and is used within a specialist plan for selected prostate cancers. Whether it is combined with another hormonal treatment depends on the treatment goal and disease setting.
Key points
- Bicalutamide is part of an oncology plan and should not be started, stopped or switched using catalogue information alone.
- Liver function, anticoagulants and the accompanying hormone treatment require review.
- Yellow skin or eyes, severe abdominal pain, breathing difficulty or facial swelling needs urgent assessment.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
What Bicalutamide is used for
Bicalutamide may be used for advanced prostate cancer or in other selected prostate-cancer settings, often alongside treatment that reduces androgen production.
How it works
Bicalutamide blocks androgen receptors, reducing signals that can drive the growth of androgen-sensitive prostate-cancer cells.
Important safety checks
Liver function may require monitoring. Warfarin and other medicines need interaction review. Breast tenderness, reduced sexual function and hot flushes can occur. Pregnant people should not handle damaged tablets because the medicine may harm a developing fetus.
When to seek urgent care
Seek urgent help for yellow skin or eyes, dark urine, severe upper-abdominal pain, persistent vomiting, facial swelling, breathing difficulty or a severe widespread rash.